Braskem Calls Annual General Meeting to Vote on 2025 Financials and Elect Board
BAK sits 53% above its 52-week low of $2.32 on elevated volume (3.5× avg).
Summary
Braskem S.A. has called its Annual General Meeting for April 29, 2026, where shareholders will vote on the recently disclosed 2025 financial statements, which reported a substantial net loss, and elect new board members.
Key Events · Corporate Governance and Compliance · BAK
-
Annual General Meeting Called
Braskem S.A. will hold its Annual General Meeting (AGM) on April 29, 2026, exclusively through a digital platform.
-
Vote on 2025 Financial Statements
Shareholders will examine, discuss, and vote on the company's financial statements for the fiscal year ended December 31, 2025. This follows recent disclosures of a R$10.96 billion net loss and negative equity for 2025.
-
Board and Fiscal Council Elections
The agenda includes the deliberation and election of effective and alternate members for both the Board of Directors and the Fiscal Council, including the Chair and Vice-Chair of the Board.
-
Executive Compensation Approval
Shareholders will also fix the annual and global compensation for administrators and Fiscal Council members for the fiscal year ending December 31, 2026.
Analysis · BAK · Industrial Applications And Services
This filing announces the Annual General Meeting (AGM) where shareholders will formally vote on the company's 2025 financial statements. This is a critical governance event, directly following the recent disclosure of a significant net loss of R$10.96 billion and negative equity for 2025. The meeting also includes the election of Board of Directors and Fiscal Council members, and the approval of executive compensation, which will shape the company's leadership and oversight in the wake of its challenging financial performance.
At the time of this filing, BAK was trading at $3.55 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.32 to $5.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.